Peter Salzmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Immunovant in a research note issued on Monday, April 8th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of ($0.49) for the quarter, down from their […]

Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Truist Financial in a report issued on Monday, Benzinga reports. They presently have a $48.00 price target on the stock. Truist Financial’s price target indicates a potential upside of 47.28% from the stock’s previous close. A number of […]

Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Truist Financial in a report issued on Monday, Benzinga reports. They presently have a $48.00 price target on the stock. Truist Financial’s price objective indicates a potential upside of 47.28% from the stock’s previous close. Several other brokerages have […]

Profund Advisors LLC grew its stake in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 9.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,869 shares of the company’s stock after acquiring an additional 4,115 shares during the quarter. Profund Advisors […]